Literature DB >> 11464282

A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene.

L Feng1, K A Lee.   

Abstract

Chromosomal fusion of the N-terminal region of the Ewings Sarcoma Oncogene (EWS-activation-domain, EAD) to the DNA-binding domains of a variety of cellular transcription factors produce oncogenic proteins (EWS-fusion proteins (EFPs)) that cause distinct malignancies. In EFPs, the EAD acts as a potent transcriptional activation domain and this ability is repressed in the context of normal, non-tumorigenic, EWS. Trans-activation by the EAD is therefore a specific characteristic of EFPs and it is thought that EFPs induce tumorigenesis via improper transcriptional activation of cellular genes. Functional elements required for transcriptional activation are dispersed throughout the EAD, as are thirty-one copies of a Degenerate Hexapeptide Repeat (DHR, consensus SYGQQS). This suggests that the EAD contains a highly reiterated functional element related to DHRs. Here we show that in the context of EWS/ATF1, the EFP that causes malignant melanoma of soft parts, trans-cooperation by small regions of the EAD ( approximately 30 residues) results in potent transcriptional activation dependent on the conserved tyrosine residues present in DHRs. These findings provide the first evidence for a role of DHRs in EAD-mediated trans-activation and demonstrate that the EAD represents a novel tyrosine-dependent transcriptional activation domain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464282     DOI: 10.1038/sj.onc.1204522

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  In vitro interaction between the N-terminus of the Ewing's sarcoma protein and the subunit of RNA polymerase II hsRPB7.

Authors:  Roumiana Todorova
Journal:  Mol Biol Rep       Date:  2008-07-08       Impact factor: 2.316

2.  Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.

Authors:  Cristina R Antonescu; Sylvia J Tschernyavsky; James M Woodruff; Achim A Jungbluth; Murray F Brennan; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

3.  A transcription assay for EWS oncoproteins in Xenopus oocytes.

Authors:  King Pan Ng; Felix Cheung; Kevin A W Lee
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

4.  RGG boxes within the TET/FET family of RNA-binding proteins are functionally distinct.

Authors:  Bess Ling Chau; King Pan Ng; Kim K C Li; Kevin A W Lee
Journal:  Transcription       Date:  2016-05-09

5.  Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.

Authors:  King Pan Ng; Gary Potikyan; Rupert O V Savene; Christopher T Denny; Vladimir N Uversky; Kevin A W Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

6.  Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family.

Authors:  Heinrich Kovar
Journal:  Sarcoma       Date:  2010-12-09

7.  Polycation-π interactions are a driving force for molecular recognition by an intrinsically disordered oncoprotein family.

Authors:  Jianhui Song; Sheung Chun Ng; Peter Tompa; Kevin A W Lee; Hue Sun Chan
Journal:  PLoS Comput Biol       Date:  2013-09-26       Impact factor: 4.475

8.  A single aromatic residue in transcriptional repressor protein KorA is critical for cooperativity with its co-regulator KorB.

Authors:  Lewis E H Bingle; Karthik V Rajasekar; Sidra tul Muntaha; Vinod Nadella; Eva I Hyde; Christopher M Thomas
Journal:  Mol Microbiol       Date:  2008-10-17       Impact factor: 3.501

9.  RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains.

Authors:  Deepa Alex; Kevin A W Lee
Journal:  Nucleic Acids Res       Date:  2005-03-02       Impact factor: 16.971

10.  The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.

Authors:  K K C Li; J Goodall; C R Goding; S-K Liao; C-H Wang; Y-C Lin; H Hiraga; T Nojima; K Nagashima; K-L Schaefer; K A W Lee
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.